APA (7th ed.) Citation

Gabriel, R., Boukichou-Abdelkader, N., Gilis-Januszewska, A., Makrilakis, K., Gómez-Huelgas, R., Kamenov, Z., . . . Silva, L. (2023). Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled Trial. Journal of Clinical Medicine, 12(5), 2035. https://doi.org/10.3390/jcm12052035

Chicago Style (17th ed.) Citation

Gabriel, Rafael, et al. "Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled Trial." Journal of Clinical Medicine 12, no. 5 (2023): 2035. https://doi.org/10.3390/jcm12052035.

MLA (9th ed.) Citation

Gabriel, Rafael, et al. "Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled Trial." Journal of Clinical Medicine, vol. 12, no. 5, 2023, p. 2035, https://doi.org/10.3390/jcm12052035.